Dublin, Oct. 18, 2023 (GLOBE NEWSWIRE) -- The "Antibody Discovery Market: Focus on Services and Platforms - Distribution by Type of Service Offered, Antibody Discovery Method, Type of Antibody Generated, Nature of Antibody Generated, Therapeutic Areas and Key Geographies: Industry Trends and Global Forecasts, 2023-2035" report has been added to ResearchAndMarkets.com's offering.
The global antibody discovery services and platforms market is poised for significant growth, with a projected value of over $1.6 billion in 2023 and a forecasted Compound Annual Growth Rate (CAGR) of 12.0% during the coming years. The market is driven by pharmaceutical companies' increasing reliance on outsourcing antibody discovery processes and the growing demand for targeted therapies.
Streamlining Drug Development with Outsourcing
The traditional drug development process is lengthy, spanning 10-15 years and involving investments of over $2 billion. Despite these efforts and investments, more than 90% of drug candidates fail in clinical trials. To streamline drug development, reduce timelines, and mitigate financial risks associated with failed trials, pharmaceutical companies are increasingly outsourcing their discovery-stage operations to specialized contract research organizations (CROs). Outsourcing allows companies to optimize resource utilization, save costs, and tap into a global network of scientific talent, ultimately enhancing the efficiency and success rate of bringing novel antibody-based therapeutics to market.
Evolution of Monoclonal Antibodies
Since the approval of the first monoclonal antibody-based therapy, Orthoclone OKT3, in 1986, monoclonal antibodies have become a versatile class of biopharmaceuticals. These antibodies have seen significant advancements in engineering, format diversification, and discovery methods. Over 160 monoclonal antibodies have been approved worldwide for the treatment of diseases such as cancer, chronic inflammatory diseases, infectious diseases, and cardiovascular diseases. Recent approvals include ELREXFIOT, TALVEYT, Rystiggo, COLUMVI, and EPKINLYT. Due to the complexities associated with discovering such antibodies, many firms are licensing and utilizing specialized antibody discovery platforms and technologies, driving the growth of the antibody discovery services and platforms market.
Market Drivers: Biotech Advancements and Increasing Demand
Key drivers of the global antibody discovery services and platforms market include recent advancements in biotechnology, a growing demand for targeted therapies, rising prevalence of chronic diseases, increased R&D expenditure in the pharmaceutical industry, and a growing trend of outsourcing antibody discovery. Collaborations between academic institutions and antibody discovery companies further contribute to market growth.
Market Size and Segments
The global market size for antibody discovery services and platforms is projected to grow at an annualized CAGR of 11.0% during the forecast period. The hit generation segment holds the largest market share, driven by its significance in R&D expenditure. In terms of the antibody discovery method, the hybridoma method is dominant, thanks to its capability to create immortalized cell lines for continuous antibody manufacturing.
Regional Analysis: North America Leads
North America currently captures nearly 40% of the market, driven by a rising interest in advanced antibody discovery platforms and increased outsourcing in the pharmaceutical industry. North America is anticipated to grow at a CAGR of 12% during the forecast period.
Key Players and Recent Developments
Key players in the antibody discovery services and platforms market include Ablexis, Antibody Solutions, ChemPartner, GenScript, Genmab, Harbour BioMed, ImmunoPrecise, Mabsilico, and more. Recent developments in the field include the launch of transgenic mouse-based antibody discovery platforms and initiatives to support the discovery of bispecific antibody formats.
Recent Developments:
- In June 2023, AbTherx announced the launch of its transgenic mouse-based antibody discovery platform, AtlasT Mice.
- In June 2023, Sanyou Biopharmaceuticals, a China-based company, launched its Sanyou Super Trillion Common Light Chain Antibody Discovery Platform, which supports the discovery of bispecific antibody formats.
- In January 2023, IASO Biotherapeutics raised USD 75 million in a venture series C round, highlighting the increasing funding activity in the antibody drug discovery service and platform domain.
- In March 2023, Twist Bioscience announced the launch of its antibody discovery services under the Twist Biopharma Solutions subsidiary after acquiring Abveris, an antibody discovery CRO, in 2022.
Key Topics Covered:
1. PREFACE
2. RESEARCH METHODOLOGY
3. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS
4. EXECUTIVE SUMMARY
5. INTRODUCTION
6. ANTIBODY DISCOVERY: PROCESS AND METHODS
7. ANTIBODY DISCOVERY SERVICE PROVIDERS: MARKET LANDSCAPE
8. COMPANY COMPETITIVENESS ANALYSIS
9. COMPANY PROFILES: ANTIBODY DISCOVERY SERVICE PROVIDERS
10. ANTIBODY DISCOVERY TECHNOLOGIES: MARKET LANDSCAPE
11. TECHNOLOGY COMPETITIVENESS ANALYSIS
12. COMPANY PROFILES: ANTIBODY DISCOVERY PLATFORM PROVIDERS
13. PARTNERSHIPS AND COLLABORATIONS
14. FUNDING AND INVESTMENT ANALYSIS
15. MARKET IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES
16. GLOBAL ANTIBODY DISCOVERY SERVICES MARKET
17. ANTIBODY DISCOVERY SERVICES MARKET, BY TYPE OF SERVICE OFFERED
18. ANTIBODY DISCOVERY SERVICES MARKET, BY TYPE OF ANTIBODY DISCOVERY METHOD
19. ANTIBODY DISCOVERY SERVICES MARKET, BY NATURE OF ANTIBODY DISCOVERED
20. ANTIBODY DISCOVERY SERVICES MARKET, BY TYPE OF THERAPEUTIC AREAS
21. ANTIBODY DISCOVERY SERVICES MARKET, BY KEY GEOGRAPHIES
22. GLOBAL ANTIBODY DISCOVERY TECHNOLOGIES MARKET
23. ANTIBODY DISCOVERY TECHNOLOGIES MARKET, BY TYPE OF ANTIBODY DISCOVERED
24. ANTIBODY DISCOVERY TECHNOLOGIES MARKET, BY KEY GEOGRAPHIES
25. LICENSING DEAL STRUCTURE
26. SWOT ANALYSIS: ANTIBODY HUMANIZATION SERVICE PROVIDERS
27. CASE IN POINT: DRUG DISCOVERY PROCESSES OF TOP SELLING ANTIBODIES
28. FUTURE GROWTH OPPORTUNITIES IN ANTIBODY DISCOVERY
29. CONCLUSION
30. EXECUTIVE INSIGHTS
31. APPENDIX 1: TABULATED DATA
32. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATION
Companies Mentioned
- 2BScientific
- 3SBio
- AAT Bioquest
- Ab Initio Biotherapeutics
- Ab Studio
- ABBA Therapeutics
- AbBioSci
- Abbiotec
- AbbVie
- Abcalis
- Abcam
- AbCellera
- Abcentra (formerly CardioVax)
- Abcepta
- AbCheck
- Abclonal
- Abcore
- ABDYS
- Abeome
- Abexxa Biologics
- ABGENEX
- AbGenics Life Sciences
- Abilita Bio
- ABL Bio
- Ablexis
- Ablynx
- Abnova
- Abpro
- AbSano
- Absci
- Absea Biotechnology
- Absolute Antibody
- Abterra Biosciences
- AbTherx
- AbTis
- Abveris (Acquired by Twist Bioscience)
- AbVision
- Abwiz Bio
- Abzena
- Abzyme Therapeutics
- AC Immune
- Acceleron Pharma
- Accurus Biosciences
- AceMab
- Achaogen
- Aclys Bio
- ACROBiosystems
- ACYTE Biotech
- Adagene
- Adaptate Biotherapeutics
- ADC Therapeutics
- Adcentrx Therapeutics
- Adimab
- AdipoGen Life Sciences
- Administration for Strategic Preparedness and Response (ASPR)
- Aduro Biotech
- AffinityImmuno
- AFSBio
- Aganitha
- Agency for Science, Technology and Research
- Agenus
- Agro-Bio
- AIMM Therapeutics
- Aimmune Therapeutics
- Akeagen
- Akeso
- Akeso Biopharma
- Alacrita
- Alamar Biosciences
- Aldevron
- Alector
- Alexion
- AlivaMab Discovery Services
- Alligator Bioscience
- Allogene Therapeutics
- Alloy Therapeutics
- Almirall
- AlpalifeBio
- ALSA Ventures
- Alvaxa Biosciences (Acquired by Sensei Biotherapeutics)
- ALX Oncology
- Alytas Therapeutics
- Amerigo Scientific
- Amgen
- AMSBIO
- Analytics Engine
- AnaptysBio
- Angios
- Annoron Biotechnology
- Antengene
- Antibodies Incorporated
- Antibodies-online
- Antibody Analytics
- Antibody Design Labs
- Antibody Production Services (A division of Life Science Group)
- Antibody Solutions
- Antiverse
- AP Biosciences
- Apexigen
- APITBIO
- Applied Biological Materials
- Applied StemCell
- AprilBio
- Aptevo Therapeutics
- Aragen Life Sciences
- Aravive
- Arctoris
- Arcus Biosciences
- argenx
- Aridis Pharmaceuticals
- aRNAy Sciences
- Aro Biotherapeutics
- Aronora
- Arsanis
- Artizan Biosciences
- Arvinas
- ARVYS Proteins
- AskGene Pharma
- Astellas
- AstraZeneca
- aTen Therapeutics
- Atlantis Bioscience
- Atlas Venture
- Atreca
- ATUM
- Aureka
- Aurigene Pharmaceutical Services
- Autolus Therapeutics
- Automated Lab Solutions
- AvantGen
- Aviva Systems Biology
- AxioMx
- Axxora
- Bayer
- BBI Group
- BBI Solutions
- Beckman Coulter
- BeiGene
- BenevolentAI
- Berkeley Lights
- Betta Pharmaceuticals
- Bhami's Research Laboratories
- Bhat Bio-tech India
- Big Cypress Acquisition
- BigHat Biosciences
- Bill & Melinda Gates Foundation
- Bill & Melinda Gates Medical Research Institute
- Bio Bench
- BioArctic
- BioAtla
- BioBench Solutions
- Biochem Pharma
- BioClue (Acquired by ImmunoPrecise Antibodies)
- Bio-Connect
- Biocure Technology
- Biocytogen
- BioD
- BioDuro-Sundia
- Biogen
- BioHub International Trade
- Bioinborn Scientific
- Biointron
- BioInvent
- BioKey (Acquired by ImmunoPrecise Antibodies)
- Biologics International
- Biomolecular Discovery Services
- BioNTech
- Bioqube Ventures
- Bio-Rad Laboratories
- Biosion
- BioStrand (Acquired by ImmunoPrecise Antibodies)
- Biosynth
- Biotalys
- Bio-Techne
- Biotecnol
- BIOTEM
- BioTeZ
- Biotheus
- BioTickle
- BioVision
- BioXpress Therapeutics
- Bird Rock Bio
- Blue Sky BioServices (Acquired by LakePharma)
- BlueBird Bio
- Bluejay Therapeutics
- Boan Biotech
- Boehringer Ingelheim
- Bolt Biotherapeutics
- Boster Biological Technology
- Bristol Myers Squibb
- Broteio Pharma
- CALIXAR
- Cambridge Research Biochemicals
- CANbridge Pharmaceuticals
- Cancer Research UK
- Cantargia
- Capra Science
- Capralogics
- Caris Life Sciences
- Carterra
- CASI Pharmaceuticals
- Catalent Biologics
- Cayman Chemical
- CD ComputaBio
- CDI Laboratories
- Celexion
- Celgene
- Cell Signaling Technology
- Celltrion
- Celros Biotech
- Celsius Therapeutics
- Centre for Applied Medical Research
- Centers for Disease Control and Prevention
- Charles River
- ChemBio Discovery Solutions
- ChemPartner
- Cherry Biolabs
- Chia Tai Tianqing Pharmaceutical
- Chiome Bioscience
- Chipscreen Biosciences
- ChromoTek
- Chugai Pharmabody Research
- Chugai Pharmaceutical
- Cidara Therapeutics
- Cilag
- Citryll
- City of Hope
- Cizzle Biotechnology
- Clayton Biotechnologies
- Click Chemistry Tools
- Clinica Universidad de Navarra
- CliniSciences
- Columbia University Irving Medical Center
- Compass Therapeutics
- Context Therapeutics
- Coronavirus Immunotherapy Consortium
- Corvidia Therapeutics
- Cosmo Bio
- CP Qingdao
- Creative Bioarray
- Creative Biolabs
- Creative Biostructure
- Creative Diagnostics
- Crescendo Biologics
- Crystal Bioscience
- CSL Behring
- Cstone Pharmaceuticals
- CureVac
- Curia
- CUSABIO
- Cyclogenix
- Cygnus Technologies
- DAAN Biotherapeutics
- Daiichi Sankyo
- Dako
- Dana-Farber Cancer Institute
- Danaher
- DaTaMabs
- DBA Italia
- Deerfield Discovery and Development
- Denali Therapeutics
- DetaiBio
- Diagnostic BioSystems
- Diatheva
- Digital Proteomics
- Dingkang Biology
- discoveric bio
- Distributed Bio
- DJS Antibodies
- Dragonfly Therapeutics
- E2DG
- Eisai
- Elabscience
- Eli Lilly and Company
- Elpis Biopharmaceuticals
- Emergent BioSolutions
- Empirico
- e-nnovation Life Sciences
- ENPICOM
- Enthera
- Entos Pharmaceuticals
- Envigo
- EpimAb Biotherapeutics
- EQRx
- Erasmus MC
- Ethris
- Eureka Therapeutics
- Eurofins Discovery
- Everest Medicines
- Evitria
- Evotec
- EVQLV
- Exelixis
- ExeVir Bio
- Exiris
- exonbio
- Exscientia
- Faculta (Acquired by Prosci)
- FairJourney Biologics
- Faron Pharmaceuticals
- Ferring Pharmaceuticals
- FibroGen
- Five Prime Therapeutics
- Fluoroprobes
- Forty Seven
- Foundery Innovations
- Fred Hutchinson Cancer Center
- Frederick National Laboratory for Cancer Research
- French Institute of Health and Medical Research
- Frugi Biotechnology
- Funakoshi
- Fusion Antibodies
- Fusion Pharmaceuticals
- G&P Biosciences
- G.CLIPS BIOTECH
- Gator Bio
- Genagon Therapeutics
- Gene Techno Science
- GeneBeyond
- Genedata
- GeneFrontier
- GENEWIZ (Acquired by Azenta Life Sciences)
- GeneX India Bioscience
- Genmab
- Genome Institute of Singapore
- Genor Biopharma
- GenoSafe
- Genovac
- GenScript
- Genuv
- Gen-Y Biologics
- GigaGen
- Gilead Sciences
- Gladstone Institutes
- Glenmark Pharmaceuticals
- Glythera
- Gmax Biopharm
- Government of British Columbia
- Government of Canada
- Green Mountain Antibodies
- Grenoble Hospital
- GSK
- Gustave Roussy
- GV20 Therapeutics
- HaemaLogiX
- Hangzhou Qiantang River Electric
- Harbour Antibodies
- Harbour BioMed
- Harpoon Therapeutics
- HD Biosciences
- Helix BioPharma
- Jiangsu Hengrui Pharmaceuticals
- Henlix Biotech
- Heptares Therapeutics
- HI-Bio
- HiFiBiO Therapeutics
- Himalaya Therapeutics
- H-Immune Therapeutics (Acquired by HiFiBiO Therapeutics)
- HJB
- Holzel Diagnostika Handels
- Horizon Discovery
- Hualan Genetic Engineering
- Hubrecht Institute
- Humanigen
- Hummingbird Bioscience
- I&L Biosystems
- i2 Pharmaceuticals
- IAMA France
- IASO Biotherapeutics
- Ibex Biosciences
- iBio
- Icagen
- Icosagen
- IGEM Therapeutics
- IgGenix
- IGM Biosciences
- I-Mab Biopharma
- iMetabolic Biopharma
- Immatics Biotechnologies
- Immorna
- Immune Biosolutions
- Immune Pharmaceuticals
- Immunitas Therapeutics
- immunitoAI
- Immunochem
- ImmunoChina Pharmaceuticals
- ImmunoGenes
- Immunome
- Immunomic Therapeutics
- ImmunoPrecise Antibodies
- ImmunoQure
- Immusmol
- Immutep
- In-Cell-Art
- Incyte
- Indivumed
- InflaRx
- Inhibrx
- Innate Pharma
- InnoBation Bio
- Innovagen
- Innovative Targeting Solutions
- Innovent
- Inotiv
- InstaDeep
- Institute for Research in Biomedicine
- Intarcia Therapeutics (Acquired by i2o Therapeutics)
- Integral Molecular
- Integrated DNA Technologies
- International Livestock Research Institute
- Invenra
- Invetx
- IONTAS
- IRBM
- Isogenica
- Italian National Institute of Health
- ITBMed
- iTeos Therapeutics
- Janssen
- Jazz Pharmaceuticals
- Johnson & Johnson Innovation
- Jotbody
- Jounce Therapeutics
- Juno Therapeutics
- Junshi Biosciences
- Just Biotherapeutics
- JW Pharmaceuticals
- Kadmon
- Kairos Therapeutics
- KAKEN PHARMACEUTICAL
- Kanwhish Biotechnology
- KareBay Biochem
- Karolinska University Hospital
- Kemp Proteins
- KGbio
- Kite Pharma
- KMD Bioscience
- Kodiak Sciences
- KYinno
- Kymab
- Kyoritsuseiyaku
- Kyowa Kirin
- La Jolla Institute for Immunology
- LabGenius
- Labtoo
- LakePharma
- LamKap Bio
- LAMPIRE Biological Labs
- Lanier Biotherapeutics
- Lava Therapeutics
- Leadgene Biomedical
- Leading Biology
- Leads Biolabs
- LegoChem Biosciences
- Leica Microsystems
- LEO Pharma
- LG Chem
- LifeArc
- LifeTein
- Ligand Pharmaceuticals
- Light Chain Bioscience
- Lineage Cell Therapeutics
- Lonza
- Loxo Oncology
- Lunaphore
- Lundbeck
- Luye Pharma
- MAB Discovery
- MabGenesis
- Mablytics
- Mabpharm
- MAbSilico
- mAbsolve
- MabSpace Biosciences
- Mabtech
- MabVax
- Mabworks
- MacroGenics
- Magenta Therapeutics
- Maine Biotechnology Services
- Maravai LifeSciences
- Masaachusetts General Hospital
- Mass Biologics
- Maverick Therapeutics
- Beijing Mede Taikang Biotechnology
- MedAbome
- MedGenome
- Medicilon
- MedImmune
- Medix Biochemica
- MEDx
- MEMO Therapeutics
- Memorial Sloan Kettering Cancer Center
- Merck
- Merus
- Mila
- MI-mAbs
- Mithra Pharmaceuticals
- Mitsubishi Tanabe Pharma Corporation
- Moderna
- ModeX Therapeutics
- ModiQuest
- Molcure
- Molecular Devices
- Molecular Templates
- MolMed
- Mologic
- Moradec
- MorphoSys
- Mount Sinai
- MSD
- MSM Protein Technologies
- Mycenax Biotech
- Myrio Therapeutics
- Mythic Therapeutics
- Nanjing Chia-Tai Tianqing Pharmaceutical Company
- Nanocarry Therapeutics
- NanoCellect Biomedical
- NanoString Technologies
- National Cancer Institute
- National Research Council of Canada's Human Health Therapeutics Research Centre
- National, Heart, Lung, and Blood Institute
- NaturalAntibody
- Nautilus Systems
- NB Health Laboratory
- NBE Therapeutics
- Nelum
- NeoBiotechnologies
- NeoClone
- Neon Therapeutics
- neoX Biotech
- Neurimmune
- Nexum
- Nidus MB Technologies
- Nidus BioSciences
- Nkarta
- Nona BioSciences
- Nordic Society of Gynaecological Oncology
- Normunity
- North Dakota State University
- Northway Biotech
- NovaRock Biotherapeutics
- Novartis
- Novo Holdings
- Novo Nordisk
- Numab Therapeutics
- NYU Langone Health
- Oak BioSciences
- Oblique Therapeutics
- Olympic Protein Technologies
- OmniAb
- OncoC4
- OncoOne
- OncoResponse
- Oncothyreon
- Onena Medicines
- Ono Pharmaceuticals
- Open Monoclonal Technology
- Optimeos Life Sciences
- OREGA Biotech
- OriCell
- OriGene Technologies
- OriMAbs
- Orion
- OSE Immunotherapeutics
- Ossianix
- Oxford Biomedica
- OXGENE
- Pandion Therapeutics
- Panoply Bio
- Paragon Therapeutics
- Pascal Biosciences
- Pediatric Brain Tumor Consortium
- Penn Medicine
- PerkinElmer
- Perseus Proteomics
- Pfizer
- pH Pharma
- Phanes Therapeutics
- PharmAbcine
- PharmAbs
- PharmaEssentia Innovation Research Center
- PharmaLegacy
- Pharmsynthez
- Pierre Fabre
- Pinteon Therapeutics
- Pioneering Medicines
- Pionyr Immunotherapeutics
- Potenza Therapeutics
- Precision Antibody
- Prellis Biologics
- ProMab Biotechnologies
- Prometheus Authors
- Prosci
- Protein Alternatives
- Proteogenix
- ProteoNic
- ProtTech
- Purdue Pharma
- Pure Biologics
- PX'Therapeutics
- QIMR Berghofer Medical Research Institute
- QoolAbs
- Quadira Biosciences
- Queen's University
- Rallybio
- Rapid Novor
- RayBiotech
- RD Biotech
- ReCentrics Biotechnology
- Regeneron Pharmaceuticals
- Resonant Therapeutics
- Retrogenix
- RevMab Biosciences
- Revolve Biotechnologies
- Rezolute
- Roche
- Rockland Immunochemicals
- RubrYc Therapeutics
- Rx Biosciences
- RxBiologics
- SAb Biotherapeutics
- Saccharo
- Salipro Biotech
- San Diego Biomedical Research Institute
- Sanders Tri-Institutional Therapeutics Discovery Institute
- Sanofi
- Sanyou Biopharmaceuticals
- Sartorius
- SBH Sciences
- Scandion Oncology
- Scotia Biologics
- Sea Lane Biotechnologies
- Selecxine
- Sema4
- Sensei Biotherapeutics
- Serum Institute of India
- Servier
- Severance Hospital
- Sevion Therapeutics
- Shanghai Henlius Biotech
- Shanghai KangaBio
- Shanghai Pidu Biotechnology
- Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry RAS
- Shire
- Sichuan Kelun-Biotech Biopharmaceutical
- Siegfried Holding
- Simcere
- Simon Fraser University
- Single Cell Technology
- Sino Biological
- Sinobioway
- Sinopharm
- SmartPharm Therapeutics
- Sorrento Therapeutics
- SOTIO
- SouthernBiotech
- Specialised Therapeutics
- Specifica
- Sphere Fluidics
- Stanford University
- Straterx
- Summit Therapeutics
- Sunshine Guojian
- Surface Oncology
- Surrozen
- Sutro Biopharma
- Suzhou Bright Scistar Biotechnology Company
- Syd Labs
- Symphogen
- Synaffix
- Synbio Technologies
- Syngene
- Synthelis
- Tachyon Therapeutics
- Takeda
- Tanabe Research Laboratories
- Tasgen Biotech (Acquried by I-Mab Biopharma)
- Tasly Biopharmaceuticals
- Taurus Biosciences
- TC BioPharm
- Technical University of Denmark
- Telesis Bio
- Telix Pharmaceuticals
- Tempus Labs
- TeneoBio
- TESARO
- Tetra Partner Network
- Tetragenetics
- Teva Pharmaceuticals
- TG Therapeutics
- The Antibody Company
- The Wistar Institute
- Theraclone Sciences
- Theranyx
- ThermoFisher Scientific
- Third Venture Biopharma
- ThromboGenics
- Tizona Therapeutics
- Tmunity Therapeutics
- Torch Biosciences
- TRACON Pharmaceuticals
- TRANSCENTA
- Transgene
- TRIANNI
- Tsinghua University
- Tubulis
- Twist Bioscience
- U.S. Naval Medical Research Unit No. 3
- UCLA Technology Development Group
- Universiti Sains Malaysia
- University College London
- University of Manchester
- University of Oxford
- University of Pennsylvania
- University of Southampton
- University of Surrey
- University of Texas MD Anderson Cancer Center
- University of Tokyo
- University of Zurich
- U-Protein (Acquired by ImmunoPrecise Antibodies)
- Utrecht University
- Vaccinex
- ValenzaBio (Acquired by ACELYRIN)
- Vall d'Hebron Institute of Oncology
- Valneva
- VBI Vaccines
- VectorB2B
- venBio Partners
- VERAXA Biotech
- Vir Biotechnology
- ViralClear Pharmaceuticals
- Visterra
- Viva Biotech
- Voyager Therapeutics
- Washington University
- Washington University School of Medicine
- Westlake Pharmaceuticals Services
- Westlake Therapeutics
- Wisconsin Alumni Research Foundation
- Worg Pharmaceuticals
- WuXi AppTec
- WuXi Biologics
- WuXi STA
- Wyss Institute
- XBiotech
- xCella Biosciences
- X-Chem
- Xencor
- XOMA
- Y- Biologics
- Yale Cancer Center
- Yangyang
- YenZym Antibodies
- Yinuoke
- Ymmunobio
- YUMAB
- Yurogen Biosystems
- Zai Lab
- Zebra Biologics
- Zhejiang Doer Biologics
- Zhejiang Teruisi Biopharmaceuticals
- Zoetis
- ZoonBio Biotechnology
- Zumutor Biologics
- Zydus
- Zymeworks
For more information about this report visit https://www.researchandmarkets.com/r/keoqk5
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
